E B S-Emergent BioSolutions Secures US FDA Approval Of CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), Previously Known As AV7909, A Two-Dose Anthrax Vaccine For Post-Exposure Prophylaxis Use
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.